OBS Medical’s CEO – Peter Leyland will be presenting Visensia® – The Safety Index™ at Swiss Re – “Transforming Healthcare: Telemedicine, best practice and you” event on the 24th Feb 2015.
Read More...
OBS Medical is pleased to announce its selection of Arazy Group Consultants Inc.’s – LICENSALE.COM™ technology to streamline the registration of Visensia® – The Safety Index™ for new and emerging markets.
Read More...
OBS Medical will be piloting Visensia® Mobile, with the aim of improving patient safety and outcomes, through the early detection of patient deterioration as a result of the continuous monitoring of three key vital signs (Heart Rate, SpO2 and Respiration Rate)
Read More...
Every year OBS Medical attends the CHC Conference to showcase the latest developments in the Visensia® software and to meet with new and existing clients to share in our experiences using Visensia® to enhance patient safety.
Read More...